Open AccessCARDIOCYTOPROTECTION – THE OBJECTIVATED POSSIBILITIES AT CARDIOVASCULAR DISEASES
Author(s) -
V.K. Tashchuk,
G.I. Hrebtii,
T.S. Vovchok,
М.О. Vintoniak,
V.V. Anfilofiieva
Publication year - 2022
Publication title -
klìnìčna ta eksperimentalʹna patologìâ
Language(s) - English
Resource type - Journals
eISSN - 2521-1153
pISSN - 1727-4338
DOI - 10.24061/1727-4338.xx.4.78.2021.18
Subject(s) - medicine , endothelial dysfunction , endothelium , coronary artery disease , disease , arginine , cardiology , coronary heart disease , intensive care medicine , biology , biochemistry , amino acid
Purpose – to objectify the results of the published clinical studies of L-arginine effectson the course of cardiovascular diseases.Conclusions. The results of the studies confirm the effectiveness of L-arginine incardiovascular diseases, in particular in hypertension, coronary heart disease, heartfailure, peripheral artery disease. Correction of endothelial dysfunction should bea routine and mandatory part of the therapeutic and prophylactic programs in thetreatment of the patients with cardiovascular pathology. The practitioner mustremember that only to stimulate depleted endothelium is ineffective, it is extremelyimportant to provide a substrate from which the endothelium can synthesize thenecessary substances.